Year archive

ARECOR THERAPEUTICS PLC — 2023 filings

All 43 regulatory filings released by ARECOR THERAPEUTICS PLC (AREC) in 2023, sourced directly from the official regulator.

43 Filings

2023 Period

2023 filings (43)

Filing	Released	Lang
Agreement with global medical products company M&A Activity	2023-12-04	English
Arecor Continues Collaboration with Lilly Regulatory Filings	2023-11-29	English
Product with Arestat technology launched in Europe Regulatory Filings	2023-11-17	English
Inhibrx milestone triggers payment to Arecor Regulatory Filings	2023-11-02	English
Exercise of rollover options & Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2023-11-01	English
Progress of Phase I clinical study of AT278 Regulatory Filings	2023-10-02	English
Arecor on Investor Meet Company Platform Report Publication Announcement	2023-09-15	English
Interim Results for six months ended 30 June 2023 Interim / Quarterly Report H1 2023	2023-09-14	English
Arecor: positive Hikma FDA pre-IND meeting Regulatory Filings	2023-09-07	English
TETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE Regulatory Filings	2023-09-04	English
Collaboration With Top 10 Global Pharma Regulatory Filings	2023-08-17	English
Notice of Interim Results Report Publication Announcement	2023-08-10	English
Arecor Business Update Regulatory Filings	2023-07-20	English
Additional Agreement with Leading Biopharma M&A Activity	2023-07-05	English
Arecor granted key patents in Europe and China Regulatory Filings	2023-06-27	English
Arecor presents positive data for AT247 at ADA Regulatory Filings	2023-06-26	English
Exercise of rollover options & Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2023-06-09	English
Result of AGM AGM Information	2023-06-09	English
AGM Statement AGM Information	2023-06-09	English
Director/PDMR Shareholding Remuneration Information	2023-05-24	English
TETRIS PHARMA LAUNCHES OGLUO® IN DENMARK & NORWAY Regulatory Filings	2023-05-15	English
ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM Report Publication Announcement	2023-05-04	English
Arecor Granted Key U.S Patent Regulatory Filings	2023-04-26	English
Arecor on Investor Meet Company Platform Report Publication Announcement	2023-04-21	English
Unaudited Preliminary Results for 2022 Earnings Release FY 2022	2023-04-20	English
Arecor Appoints Chief Business Officer Board/Management Information	2023-04-05	English
FIRST PATIENT DOSED IN AT278 CLINICAL TRIAL Regulatory Filings	2023-03-22	English
Price Monitoring Extension Regulatory Filings	2023-03-13	English
Second Price Monitoring Extn Regulatory Filings	2023-03-13	English
Price Monitoring Extension Regulatory Filings	2023-03-13	English
Second Price Monitoring Extn Regulatory Filings	2023-03-13	English
Price Monitoring Extension Regulatory Filings	2023-03-13	English
Second Price Monitoring Extn Regulatory Filings	2023-03-13	English
Price Monitoring Extension Regulatory Filings	2023-03-13	English
ARECOR TO PRESENT SHARESOC WEBINAR Regulatory Filings	2023-03-01	English
Holding(s) in Company Major Shareholding Notification	2023-02-24	English
Notice of Results Report Publication Announcement	2023-02-24	English
Arecor Granted Patents in India and the US Regulatory Filings	2023-02-16	English
ARECOR STRENGTHENS COLLABORATION WITH PARTNER Regulatory Filings	2023-02-14	English
Arecor Publishes Data for AT278 in Diabetes Care Regulatory Filings	2023-01-30	English
BUSINESS UPDATE Regulatory Filings	2023-01-19	English
ARECOR ANNOUNCES TRANSFER OF AT307 TO HIKMA Earnings Release FY 2022	2023-01-12	English
TETRIS PHARMA LAUNCHES OGLUO® IN AUSTRIA Regulatory Filings	2023-01-04	English